ClinicalTrials.Veeva

Menu

Mobile Smoking Treatment for Spanish-speaking Latinx Smokers

University of Houston logo

University of Houston

Status

Unknown

Conditions

Smoking Cessation

Treatments

Behavioral: Dejar de Fumar Asistente (Mobile App)
Behavioral: Impacto (Mobile App)

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT04417075
STUDY00001567
1R41DA048692-01 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The specific aims of the project are to develop and test a Spanish language, mobile app for smoking cessation called Impacto.

Full description

A total of 38 Spanish-speaking, Latinx smokers with high anxiety sensitivity (AS) will be recruited for this project. Eight (8) participants will complete user interviews in Spanish and thirty (30) participants will participate in a randomized controlled trial (RCT) for smoking cessation. Participants will be randomized to receive either the Impacto mobile app or a generic, Spanish language, smoking cessation, mobile app control (Dejar de Fumar Asistente).

Enrollment

38 estimated patients

Sex

All

Ages

18 to 55 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. 18 to 55 year of age, 2) current smoker (i.e., at least 6 cigarettes/day), 3) not currently engaged in smoking cessation treatment, 4), high anxiety sensitivity (AS) score defined as an ASI-III score of ≥ 23, 5) motivation to quit > 5 on a 10 pt. scale, 6) Spanish speaking, and 7) currently own an Android-compatible mobile phone.

Exclusion criteria

  1. use of other tobacco products (including e-cigarettes), 2) current non-nicotine substance dependence and/or current or intended participation in a concurrent substance abuse treatment, 3) ongoing psychotherapy of any duration directed specifically toward the treatment of anxiety or depression, or 4) active suicidality (i.e., suicidal ideation, intent, and/or plan) or current psychosis

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

38 participants in 2 patient groups

Impacto
Experimental group
Description:
This is the mobile app to be developed and evaluated in this project.
Treatment:
Behavioral: Impacto (Mobile App)
Dejar de Fumar Asistente
Active Comparator group
Description:
This is the mobile app that will serve as the control condition in evaluating the efficacy of Impacto.
Treatment:
Behavioral: Dejar de Fumar Asistente (Mobile App)

Trial contacts and locations

1

Loading...

Central trial contact

Justin M Shepherd, M.A.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems